ESGO 2026 Quiz - 2nd Round

Put Your Knowledge of Surgical Approaches in Gynaecological Oncology

To The Test

See How You Measure Up!

Let’s start.

1.

How can we identify patients with oligometastatic ovarian cancer who may benefit from local therapies?

ESGO 2026 Tumour board Session: Management of Oligometastatic Recurrent Disease in Ovarian Cancer

By relying exclusively on imaging findings

By offering local therapies to all patients with recurrent disease

By integrating clinical, radiologic, and molecular features within a multidisciplinary evaluation

By avoiding local therapies in recurrent ovarian cancer

1 out of 3

2.

How can 3D reconstruction imaging improve surgical outcomes?

ESGO 2026 Scientific Session: Surgical Trends of the Future

By increasing operative time without improving outcomes

By replacing intraoperative surgical decision-making

By eliminating the need for conventional imaging

By enabling detailed preoperative visualisation, enhancing planning, and reducing intraoperative complications

2 out of 3

3.

Can radiotherapy serve as a curative approach in recurrent ovarian cancer, or is it purely palliative?

ESGO 2026 Tumour board: Management of Oligometastatic Recurrent Disease in Ovarian Cancer

No, radiotherapy has no role beyond symptom control

Yes, while traditionally used for palliation, emerging evidence shows radiotherapy can offer durable disease control in selected patients

Yes, radiotherapy is always curative in recurrent ovarian cancer

No, radiotherapy should only be used after all systemic options are exhausted

3 out of 3

Kindly fill in your details and submit your answers to reveal the results.

Name

Email

Country

Quiz